I21M (p.Ile21Met) variant of ACTN2 (Alpha-actinin-2)
I21M (p.Ile21Met) in ACTN2 (Alpha-actinin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
I21M (p.Ile21Met) variant details
- p.Ile21Met
- NCI-TCGA Cosmic COSV6397
- cosmic curated COSV63976
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available